你即將離開本站

並前往https://oncologypro.esmo.org/meeting-resources/esmo-congress-2021/conditional-survival-and-5-year-follow-up-in-checkmate-214-first-line-nivolumab-ipilimumab-n-i-versus-sunitinib-s-in-advanced-renal-cell-car

Conditional survival and 5-year follow-up in CheckMate 214 ...

Annals of Oncology (2021) 32 (suppl_5): S678-S724. 10.1016/annonc/annonc675 ... If you do not have an ESMO account, please create one for free.

確定！ 回上一頁

查詢 「ESMO 2021」的人也找了：

  1. esmo 2022
    2.
  2. ESMO 2020
    3.
  3. esmo 2023
    4.
  4. Capdevila j et al presented at esmo 2021 abstract lba67
    5.
  5. asco 2021
    6.
  6. ESMO Asia 2023
    7.
  7. ESMO 2022 program
    8.
  8. ESMO 2022 Congress
    9.